Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Air Force made critical errors during October 7 massacre, investigator says - 2Kennedy approves adding two rare disorders to newborn screenings
- 36 Arranging Administrations to Change Your Open air Space
- 4San Francisco mayor says city in talks to bring pandas back to zoo ahead of trip to Asia
- 5Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- Southern Californians, your health insurance costs could rise in 2026
- 4 Coolers for Present day Kitchens
- Exploring the School Application Cycle: Understudy Bits of knowledge
- Apollo's impatient old-timers are rooting for NASA's return to the moon with Artemis II launch
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- The World's Dazzling Regular Miracles
- Popular Japanese Hotel Chain Now Lets You Show Up With Just Your Passport
- Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
